These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7373612)

  • 21. Fluorescent opsonization assay: binding of plasma fibronectin to fibrin-derivatized fluorescent particles does not enhance their uptake by macrophages.
    Falcone DJ
    J Leukoc Biol; 1986 Jan; 39(1):1-12. PubMed ID: 3455706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of phagocytosis. II. Analysis of in vivo clearance with demonstration of competitive inhibition between similar and dissimilar foreign particles.
    Normann SJ
    Lab Invest; 1974 Aug; 31(2):161-9. PubMed ID: 4852621
    [No Abstract]   [Full Text] [Related]  

  • 23. Kupffer cell phagocytosis and metabolism of a variety of particles as a function of opsonization.
    Saba TM; Di Luzio NR
    J Reticuloendothel Soc; 1965 Dec; 2(5):437-53. PubMed ID: 5884843
    [No Abstract]   [Full Text] [Related]  

  • 24. CD31 promotes beta1 integrin-dependent engulfment of apoptotic Jurkat T lymphocytes opsonized for phagocytosis by fibronectin.
    Vernon-Wilson EF; Auradé F; Brown SB
    J Leukoc Biol; 2006 Jun; 79(6):1260-7. PubMed ID: 16551678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opsonic fibronectin after trauma and particle injection determined by a peritoneal macrophage monolayer assay.
    Blumenstock FA; Saba TM; Roccario E; Cho E; Kaplan JE
    J Reticuloendothel Soc; 1981 Jul; 30(1):61-71. PubMed ID: 7021821
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.
    Gaynor CD; McCormack FX; Voelker DR; McGowan SE; Schlesinger LS
    J Immunol; 1995 Dec; 155(11):5343-51. PubMed ID: 7594549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-specific binding by macrophages: existence of different adhesive mechanisms and modulation by metabolic inhibitors.
    Benoliel AM; Capo C; Bongrand P; Ryter A; Depieds R
    Immunology; 1980 Nov; 41(3):547-60. PubMed ID: 7461702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibronectin as a co-factor necessary for optimal granulocyte phagocytosis of Staphylococcus aureus.
    Lanser ME; Saba TM
    J Reticuloendothel Soc; 1981 Nov; 30(5):415-24. PubMed ID: 7320999
    [No Abstract]   [Full Text] [Related]  

  • 29. Macrophage effector function. An in vitro system of assessment.
    Hersey P
    Transplantation; 1973 Mar; 15(3):282-90. PubMed ID: 4711389
    [No Abstract]   [Full Text] [Related]  

  • 30. [Opsonin requirements for phagocytosis of Enterococcus spp. by human polymorphonuclear leukocytes].
    García I; Joyanes P; Pascual A; Martínez-Martínez L; Perea EJ
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):419-22. PubMed ID: 9887629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential properties of organ-specific serum opsonins for liver and spleen macrophages.
    Moghimi SM; Patel HM
    Biochim Biophys Acta; 1989 Sep; 984(3):379-83. PubMed ID: 2775783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reticuloendothelial systemic response to operative trauma as influenced by cryoprecipitate or cold-insoluble globulin therapy.
    Saba TM; Cho E
    J Reticuloendothel Soc; 1979 Aug; 26(2):171-86. PubMed ID: 490515
    [No Abstract]   [Full Text] [Related]  

  • 33. Heparin enhancement of Kupffer cell phagocytosis in vitro.
    Kitchen AG; Megirian R
    J Reticuloendothel Soc; 1971 Jan; 9(1):13-22. PubMed ID: 5540264
    [No Abstract]   [Full Text] [Related]  

  • 34. Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383.
    Jones BG; Dickinson PA; Gumbleton M; Kellaway IW
    J Pharm Pharmacol; 2002 Aug; 54(8):1065-72. PubMed ID: 12195820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
    Leidi M; Gotti E; Bologna L; Miranda E; Rimoldi M; Sica A; Roncalli M; Palumbo GA; Introna M; Golay J
    J Immunol; 2009 Apr; 182(7):4415-22. PubMed ID: 19299742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage "activation" and the action of opsonizing antibodies in malaria.
    Brown KN; Hills LA
    Trans R Soc Trop Med Hyg; 1971; 65(1):6. PubMed ID: 4997197
    [No Abstract]   [Full Text] [Related]  

  • 37. Induction of phagocytosis of iron colloid by Ehrlich ascites tumor cells with polycationic substances.
    Yokomura E
    Gan; 1969 Aug; 60(4):439-47. PubMed ID: 5345661
    [No Abstract]   [Full Text] [Related]  

  • 38. Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent.
    Hasegawa T; Hirota K; Tomoda K; Ito F; Inagawa H; Kochi C; Soma G; Makino K; Terada H
    Colloids Surf B Biointerfaces; 2007 Nov; 60(2):221-8. PubMed ID: 17683920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced phagocytic and bactericidal activities of phospholipidotic rat alveolar macrophages.
    McNulty MJ; Reasor MJ
    J Reticuloendothel Soc; 1981 Dec; 30(6):539-49. PubMed ID: 7341774
    [No Abstract]   [Full Text] [Related]  

  • 40. Macrophage complement receptors and pathogen clearance.
    van Lookeren Campagne M; Wiesmann C; Brown EJ
    Cell Microbiol; 2007 Sep; 9(9):2095-102. PubMed ID: 17590164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.